What this means
This is a clinical trial that is still recruiting people, so it has no results yet. It aims to see if a human milk diet affects heart and blood vessel health later in life.
Plain-English summary written by an AI model from the registry listing.
- Status
- Recruiting
- Who can join
- Ages 1 Day–5 · Extremely preterm infants; no results posted yet
- Where
- 1 site
The science
- Registered title
- Exclusive Human-milk in Preterm NEOnates and Early VASCular Aging Risk Factors (NEOVASC)
- Trial ID
- NCT04413994 ↗
- Phase
- Not applicable
- Study type
- interventional
- Conditions
- Prematurity, Vascular Aging
- What is tested
- Humavant
- Sponsor
- Prolacta Bioscience
- Ages
- 1 Day to 5 Years
- Dates
- First posted Jun 4, 2020 · updated Sep 18, 2026
Registry summary
Early vascular aging has its origins in fetal and neonatal life. The NEOVASC clinical trial aims to determine the effects of an exclusive human milk diet in extremely preterm infants on long-term cardiovascular health.
Sites (1)
- Medical University of Innsbruck, Innsbruck, Tyrol, Austria